Clinical Management and Prognosis in Dilated Cardiomyopathy
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (15 June 2021) | Viewed by 4999
Special Issue Editor
Interests: cardiomyopathy; prognosis; echocardiography; systolic and diastolic cardiac function; long term outcome; cardiac transplantation; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Dilated cardiomyopathy is unfortunately a problem on the rise. It is extremely important to be able to rely on very solid prognostication parameters in order to take the right therapeutic decision, as well as to follow up the effect of some interventions. These prognostic validated parameters (such as left ventricular ejection fraction etc.) can have very practical applications in the clinical arena. Needless to say, the more quantitative and easy to obtain the better. These parameters need to be validated not only in the short-mid term but also in the long term. And they could be of assistance in understanding the effect of some interventions (pharmacological or device-based): if such parameters improve we can see that the natural history of that patient can possibly be modified by such interventions. Otherwise, the absence of modifications of such prognostic indices after appropriate intervention should induce us to conclude that transplantation may be the only possible alternative.
A multiparametric approach to prognosis is important, so not only cardiac specific parameters could help in prognostication but also other parameters; for example, renal function parameters could be useful.
In addition, now there are a multitude of interventions (device implantation etc.) in heart failure patients with dilated cardiomyopathy which can have positive effects but also drawbacks: for example, infective endocarditis after device implantation. Therefore, a more critical approach to all these interventions is of the utmost importance.
Prof. Dr. Carlo Caiati
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cardiomyopathy
- Prognosis
- Echocardiography
- Systolic and diastolic cardiac function
- Long term outcome
- Cardiac transplantation
- Heart failure
